In the TCGA database and our cohort, we found that patients with high SCGN expression had a better prognosis, and with the elevated nuclear grade and stage of ccRCC, the SCGN expression gradually decreased and eventually was completely absent 16. The gene discussed is SCGN; the disease is nonpapillary renal cell carcinoma.